Comment by
youngpupper on Jul 27, 2020 9:43am
I don't think you understand pre revenue biotechs, the business model is simple: sell any possible revenue generating assets and continue to spend/raise to dilute shareholders ! Easy money!
Comment by
Stockthoughts on Jul 27, 2020 1:52pm
I don't think you understand that Guy just sold the only company that can generate revenue and selling it for 1m-1.5 million in shares does nothing to shareholders. It is a way for Guy and his buddies to take it all for themselves at shareholders expense. They will continue making shareholder suffer (many times)